Update on the Phase 4 Confirmatory Study of ADUHELM®

Go back to Update on the Phase 4 Confirmatory Study of ADUHELM®
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 201.82 -1.13 (0.56%)
Previous Close $202.95    52 Week High $333.65 
Open $203.34    52 Week Low $223.02 
Day High $203.85    P/E 25.84 
Day Low $199.58    EPS $7.81 
Volume 940,857